Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase
The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dan, H. C., Sun, M., Yang, L., Feldman, R. I., Sui, X.-M., Ou, C. C., Nellist, M., Yeung, R. S., Halley, D. J. J., Nicosia, S. V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205838200 · Cited by 370
RetractedTSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083 · cited 2×
“…placed the TSC complex downstream of Akt and upstream of S6K, an arrangement rapidly confirmed by biochemical studies, both in Drosophila and in mammalian cells (Gao et al., 2002; Inoki et al., 2002; Kwiatkowski et al., 2002; Manning et al., 2002; Radimerski et al., 2002; Tee et al., 2002).”
BackgroundKim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
Burgering, B. M. T., & Coffer, P. J. (1995) · Nature · doi:10.1038/376599a0 · Cited by 2,089
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,006
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911 · cited 2×
“…the strong genetic (Patel et al., 2003; Saucedo et al., 2003; Stocker et al., 2003) and biochemical (Castro et al., 2003; Garami et al., 2003; Inoki et al., 2003a; Tee et al., 2003; Zhang et al., 2003) evidence that Rheb-GTP is a necessary upstream activator of TOR complex 1 signaling, what…”
BackgroundLoewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00636-6 · Cited by 1,886 · cited 1×
“Independently, Loewith et al. (2002) immunopurified epitopetagged TOR1 and TOR2 from S. cerevisiae and identified two distinct complexes; KOG1 (homologous to raptor) and LST8 were retrieved with TOR1, whereas LST8 and three different polypeptides (AVO1, 2 and 3) were recovered with TOR2.”
BackgroundRaptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
Self-citation
Cited by
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
“In its GTP-bound state, the Ras-related GTPase Rheb is a potent and essential activator of mTORC1 (Avruch et al., 2006; Huang and Manning, 2008).”
GEFs and GAPs: Critical Elements in the Control of Small G Proteins
Bos, J. L., Rehmann, H., & Wittinghofer, A. (2007) · Cell · doi:10.1016/j.cell.2007.05.018 · Cited by 1,903
“Other kinases that phosphorylate and inactivate TSC2 are ERK, PKC, and Rsk, indicating that multiple pathways converge on TSC2 (Avruch et al., 2006).”
BackgroundThe mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
The regulation and function of Class III PI3Ks: novel roles for Vps34
Backer, J. M. (2008) · Biochemical Journal · doi:10.1042/bj20071427 · Cited by 659
Convergent energy and stress signaling
Baena-González, E., & Sheen, J. (2008) · Trends in Plant Science · doi:10.1016/j.tplants.2008.06.006 · Cited by 608
Autophagy: Pathways for Self-Eating in Plant Cells
Liu, Y., & Bassham, D. C. (2012) · Annual Review of Plant Biology · doi:10.1146/annurev-arplant-042811-105441 · Cited by 600
Greer, E. L., & Brunet, A. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00459.x · Cited by 572
Insulin/insulin-like growth factor signaling in C. elegans
Murphy, C. T. (2013) · WormBook · doi:10.1895/wormbook.1.164.1 · Cited by 532
Signalling to translation: How signal transduction pathways control the protein synthetic machinery
Proud, C. G. (2007) · Biochemical Journal · doi:10.1042/bj20070024 · Cited by 520
Meikle, L., Pollizzi, K., Egnor, A., Kramvis, I., Lane, H., Sahin, M., & Kwiatkowski, D. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0955-08.2008 · Cited by 501
Assémat, E., Bazellières, E., Pallesi-Pocachard, E., Le Bivic, A., & Massey-Harroche, D. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.029 · Cited by 470
The life of a cell: apoptosis regulation by the PI3K/PKB pathway
Duronio, V. (2008) · Biochemical Journal · doi:10.1042/bj20081056 · Cited by 390
Progeria syndromes and ageing: what is the connection?
Burtner, C. R., & Kennedy, B. K. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2944 · Cited by 386
Molecular mechanisms of metabolic regulation by insulin in Drosophila
Teleman, A. A. (2010) · Biochemical Journal · doi:10.1042/bj20091181 · Cited by 384
Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer
Clemmons, D. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2359 · Cited by 340
Nutrient signalling in the regulation of human muscle protein synthesis
Fujita, S., Dreyer, H. C., Drummond, M. J., Glynn, E. L., Cadenas, J. G., Yoshizawa, F., Volpi, E., & Rasmussen, B. B. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.134593 · Cited by 339
“There has been a large amount of work in cells and rodents that has examined the effect of insulin and nutrients (primarily amino acids) in the regulation of protein synthesis (see Avruch et al. 2005, 2006; Kimball & Jefferson, 2006; Proud, 2006).”
BackgroundInfluentialStanfel, M. N., Shamieh, L. S., Kaeberlein, M., & Kennedy, B. K. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.06.007 · Cited by 335
mTOR signaling and its roles in normal and abnormal brain development
Takei, N., & Nawa, H. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00028 · Cited by 317
“Insulin is the most-characterized growth factor that activates mTORCs through the PI3K/Akt/TSC/Rheb pathway (Avruch et al., 2006).”
BackgroundHuang, J., & Klionsky, D. J. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4511 · Cited by 315
PRAS40 and PRR5-Like Protein Are New mTOR Interactors that Regulate Apoptosis
Thedieck, K., Polak, P., Kim, M. L., Molle, K. D., Cohen, A., Jenö, P., Arrieumerlou, C., & Hall, M. N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001217 · Cited by 296
Ribosomal Protein S6 Phosphorylation
(2015) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2015.07.006 · Cited by 286
Rac1 Regulates the Activity of mTORC1 and mTORC2 and Controls Cellular Size
Saci, A., Cantley, L. C., & Carpenter, C. L. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.03.017 · Cited by 275
“GTP binding of Rheb is regulated by TSC2 (tuberin), a Rheb GTPase-activating protein (GAP) (reviewed by Avruch et al., 2006).”
BackgroundDrummond, M. J., & Rasmussen, B. B. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3282fa17fb · Cited by 274
A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling
Findlay, G. M., Yan, L., Procter, J., Mieulet, V., & Lamb, R. F. (2007) · Biochemical Journal · doi:10.1042/bj20061881 · Cited by 257
Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy
Huang, X., Zhang, H., Yang, J., Wu, J., McMahon, J., Lin, Y., Cao, Z., Gruenthal, M., & Huang, Y. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.024 · Cited by 231
Self-citationPhosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
Aoyagi, T., & Matsui, T. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796390976 · Cited by 213
Chapter 1 Physiological Roles of Ribosomal Protein S6: One of Its Kind
(2008) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(08)00801-0 · Cited by 212
“This phosphorylation blocks the ability of TSC2 to act as a GTPase-activating protein (GAP) for Rheb (Ras-homolog enriched in brain), thereby allowing Rheb–GTP to accumulate and to operate as an activator of the rapamycin-sensitive TOR complex 1 (TORC1) (Avruch et al., 2006).”
BackgroundGrowth and aging: a common molecular mechanism
Blagosklonny, M. V., & Hall, M. N. (2009) · Aging · doi:10.18632/aging.100040 · Cited by 212
“absence of the other mTOR inputs but not vice versa [2], and only nutrients activate TOR in unicellular organisms.”
BackgroundSherk, A. B., Frigo, D. E., Schnackenberg, C. G., Bray, J. D., Laping, N. J., Trizna, W., Hammond, M., Patterson, J. R., Thompson, S. K., Kazmin, D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1047 · Cited by 211
“In addition, Xu and colleagues indicated that SGK1 may activate mTOR through the activation of various cellular transporters and the subsequent influx of certain nutrients and amino acids (7, 35).”
Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass
Frost, R. A., & Lang, C. H. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00089.2007 · Cited by 200
Sato, T., Nakashima, A., Guo, L., & Tamanoi, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809207200 · Cited by 196
Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle
Hornberger, T. A. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.05.007 · Cited by 170
“…has been proposed that this might involve the sequestration of the FKBP38 protein (an endogenous inhibitor of mTORC1 signaling); however, the exact mechanism through which Rheb activates mTORC1 signaling remains a subject of intense debate (Bai et al., 2007, Ma et al., 2008, Avruch et al., 2006).”
BackgroundActivation of mTOR: a culprit of Alzheimer’s disease?
Cai, Z., Zhou, Y., Xiao, M., Yan, L.-J., & He, W. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75717 · Cited by 161
Insulin Regulation of Proteostasis and Clinical Implications
James, H. A., O'Neill, B. T., & Nair, K. S. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.010 · Cited by 121
RalA Functions as an Indispensable Signal Mediator for the Nutrient-sensing System
Maehama, T., Tanaka, M., Nishina, H., Murakami, M., Kanaho, Y., & Hanada, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805822200 · Cited by 80
Fasting and rapamycin: diabetes versus benevolent glucose intolerance
Blagosklonny, M. V. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1822-8 · Cited by 74
The role of the TOR pathway in mediating the link between nutrition and longevity
Lushchak, O., Strilbytska, O., Piskovatska, V., Storey, K. B., Koliada, A., & Vaiserman, A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.03.005 · Cited by 73
Sofroniadou, S., & Goldsmith, D. (2011) · Drug Safety · doi:10.2165/11585040-000000000-00000 · Cited by 60
Probing the GTPase cycle with real-time NMR: GAP and GEF activities in cell extracts
Marshall, C. B., Meiri, D., Smith, M. J., Mazhab-Jafari, M. T., Gasmi-Seabrook, G. M. C., Rottapel, R., Stambolic, V., & Ikura, M. (2012) · Methods · doi:10.1016/j.ymeth.2012.06.014 · Cited by 46
Glynn, E. L., Lujan, H. L., Kramer, V. J., Drummond, M. J., DiCarlo, S. E., & Rasmussen, B. B. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-149 · Cited by 45
Regulation of mRNA Translation as a Conserved Mechanism of Longevity Control
Mehta, R., Chandler-Brown, D., Ramos, F. J., Shamieh, L. S., & Kaeberlein, M. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-7002-2_2 · Cited by 44
Yang, S., Zhang, Y., Ting, C.-Y., Bettedi, L., Kim, K., Ghaniam, E., & Lilly, M. A. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.08.006 · Cited by 36
Yang, P., Zhao, Y., Zhao, L., Yuan, J., Chen, Y., Varghese, Z., Moorhead, J. F., Chen, Y., & Ruan, X. Z. (2015) · Scientific Reports · doi:10.1038/srep14959 · Cited by 21
Regué, L., Wang, W., Ji, F., Avruch, J., Wang, H., & Dai, N. (2023) · Diabetes · doi:10.2337/db21-1087 · Cited by 12
Self-citationThe mTOR pathway: a common link between Alzheimer's disease and Down Syndrome
Wohlfert, A. J., Phares, J., & Granholm, A.-C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206183 · Cited by 6
“TSC is a GTPase activator that modulates the Ras homolog enriched in brain (Rheb; see Figure 2 red square) GTPase, an activator of mTORC1 [34].”
Background(2012) · PubMed
Metadata
- Authors
- Avruch, J., Hara, K., Lin, Y., Liu, M., Long, X., Ortiz-Vega, S., & Yonezawa, K.
- Venue
- Oncogene
- Published
- 2006-10-16
- Volume
- 25
- Issue
- 48
- Pages
- 6361-6372
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2009971361
- Cited by
- 296
- References
- 121
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.